inefficient (lower than 5%). Masking of FcMBL binding sites by immunoglobulins and immune cells, as well as the high viscosity of complex biological samples were found to be the main reason responsible for the low capture efficiency. However, through a pre-treatment of the clinical tissue samples with hypotonic washes, hyaluronidase and proteases, FcMBL capture efficiency increased to 76%.